Abstract 4388: The role of neoantigens in immunotherapy of cutaneous melanoma

Melanoma is increasing in incidence by up to 3% annually, and metastatic melanoma, which is resistant to most conventional therapies, has a poor prognosis with a 5-year survival rate of less than 20%. Immunotherapy is able to yield durable response in melanoma; however, the response rate is limited...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2016-07, Vol.76 (14_Supplement), p.4388-4388
Hauptverfasser: Thomas, Renee M., Day, Chi-Ping, Weaver Ohler, Zoe, El Meskini, Rajaa, Graff-Cherry, Carri, Chin, Sung, Michalowski, Aleksandra, Luo, Ji, Van Dyke, Terry, Merlino, Glenn
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!